No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Kane Biotech Inc (KNBIF) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Milestones
Kane Biotech to Raise up to $3 Million in Private Placement Offering
Kane Biotech Narrows Its Third-Quarter Loss as Revenue Rises
Kane Biotech Announces Agreement to Acquire FB Dermatology
Kane Biotech Donates Antimicrobial Wound Gel to Ukraine
Kane Biotech Announces Exclusive Distribution Agreement With XSONX
No Data